Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Vahid Bazojoo has a total of 148 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Assessing the Reliability of MRI and CT Scans for Liver Volume Estimation in Patients Undergoing Liver Transplantation

    by Vahid Bazojoo, Arman Sharbatdaran, Andrea S. Kierans, Steven Salvatore, Xinzi He, Chady Atallah, Martin R. Prince

    Objective: Magnetic resonance imaging (MRI) and computed tomography (CT) are commonly used to measure organ volumes, but accuracy has not been methodically confirmed. This research seeks to fill this gap by comparing preoperative MRI and CT for liver volumetric characterization to surgical specimen weights as a reference standard. Methods: In this cross-sectional study, we retrospectively enrolled subjects who underwent liver explant and had MRI or CT scans within 1 month preoperatively. Organs' labels were corrected by physicians after deep learning model inferences using ITK-SNAP software. Liver surgical weights were collected from pathology reports. Liver volume was estimated as liver weight (g)×a conversion factor (1.2 mL/g), taking into account density, blood loss, and post-explant changes. We excluded subjects who had gallbladder weight reported together with liver weight. For assessing the accuracy of MRI and CT scan volume measurement, we reported the average volume of all available axial, coronal, and sagittal sequences. Results: For MRI, there was no significant difference in the liver volume between sequences; the average volume over all sequences was used as the MRI measurement. There was good agreement between liver explant volume measurements on MRI [23 subjects, 26 exams, 1730 mL (1195, 2108) compared with pathology 1760 mL (1206, 2337); P =0.71] as well as between CT measurements [16 subjects, 23 exams, 1754 mL (1175, 2558) and pathology 1776 mL (1211, 2820); P =0.37]. In 5 subjects who had both MRI and CT (MRI: 1657±533 mL, CT: 1745±591 mL, surgical reference: 1750±679 mL; P =0.96), MRI and CT scans have similar high accuracy. There was a trend toward contrast-enhanced CT scans having greater volume accuracy compared with CT without contrast, with a mean error=6%±4% versus 11%±11%; P =0.29, respectively. Conclusions: Our study shows that MRI and CT scans both have high accuracy for liver volume measurements compared with surgical specimen weights. CT and MRI both accurately measured liver volume before liver explant evaluation.

  • Open Access

    Automatically Measuring Kidney, Liver, and Cyst Volumes in Autosomal Dominant Polycystic Kidney Disease

    by Qing Xiong, Xinzi He, Elisa Scalco, Siria Pasini, Chenglin Zhu, Mina C. Moghadam, Usama Sattar, Vahid Davoudi, Vahid Bazojoo, Hreedi Dev, et al.

    Key Points: TraceOrg is a web-based tool that automatically labels kidney, liver, and cysts, reporting volumes and Mayo Imaging Classification. External validation showed high performance and good generalizability on Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease, Polycystic Kidney Disease-Research Resource Consortium, and other external datasets. Training on multiple pulse sequences enables TraceOrg to process images from a wide variety of protocols. Background: Kidney, liver, and cyst volumes are important for diagnosis, classification, and management of autosomal dominant polycystic kidney disease (ADPKD) but challenging to measure accurately and reproducibly. Here, we develop a web-based deep learning platform to automatically and robustly measure kidneys, liver, and cyst volumes in ADPKD. Methods: Magnetic resonance imaging (MRI) and computed tomography scans from patients with ADPKD ( n =611) and participants without ADPKD ( n =109) were used to train a 3D hybrid model combining U-Net and transformer elements for segmenting kidneys, liver, and cysts. The model is implemented as a web-based calculator at www.traceorg.com, providing segmentation labels, volumes, and Mayo Clinic Image Classification. Automatic browser anonymization of digital imaging and communications in medicine images ensures privacy. Internal validation was conducted on 70 MRIs for kidney and liver segmentations and 46 MRIs for cyst segmentations, and performance was compared with five open access segmentation models (TotalSegmentator, MRAnnotator, Kim, Woznicki, and Gregory–Kline). External validation was performed on one single-center dataset ( n =58), one multicenter dataset ( n =73), Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease 2 (CRISP, n =30), and Polycystic Kidney Disease-Research Resource Consortium (PKD-RRC, n =115) MRIs with T2-weighted and T1-weighted images. Results: After training on 720 participants (mean age=48±15, eGFR=74±32 ml/min per 1.73 m 2 and height-adjusted total kidney volume=826±772 ml/m), TraceOrg internal validation performance achieved high mean Dice scores of 0.97 (kidneys), 0.97 (liver), 0.93 (kidney cysts), and 0.82 (liver cysts) outperforming existing models for ADPKD. External validation showed strong performance with Dice scores of 0.92–0.94 (kidney), 0.87–0.96 (liver), 0.85 (kidney cysts), and 0.76–0.90 (liver cysts) for the single-center dataset and 0.95 (kidney) and 0.81 (kidney cysts) for the multicenter dataset. Compared with CRISP volumes measured by stereology, the mean absolute percent difference was 5.3% (kidneys, n =30), 11% (kidney cysts, n =30), and 5.5% (liver, n =22). Compared with PKD-RRC ( n =115), the mean absolute percent difference in total kidney volume was 4.9%. Conclusions: TraceOrg, a publicly available web-based tool, automatically measured kidney, liver, and cyst volumes from abdominal MRI in ADPKD with high accuracy compared with manual segmentations. Podcast: This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/JASN/2026_02_03_ASN0000000904.mp3


  • Common bile duct dilatation on MRI in autosomal dominant polycystic kidney disease

    by Usama Sattar, Chenglin Zhu, Xiaorui Yin, Xianfu Luo, Vahid Bazojoo, Albert S. Prince, Hanna Rennert, Danielle Brandman, Emily Schonfeld, Jon D. Blumenfeld, et al.

    Purpose Polycystic liver disease is the most prevalent extrarenal manifestation of autosomal dominant polycystic kidney disease (ADPKD). Non-obstructive asymptomatic common bile duct (CBD) dilatation has been observed anecdotally on CT scans, but CT is not optimal for biliary visualization. Here, we measured CBD diameter on T2-weighted MRI in ADPKD subjects to determine if CBD dilatation is associated with ADPKD. Methods CBD diameter was measured retrospectively on ADPKD subjects (n = 254) and on age- and sex-matched controls without ADPKD (n = 254) who underwent abdominal MRI. CBD diameter in these groups was compared and correlated with clinical, laboratory and magnetic resonance imaging (MRI) features, including organ volumes and cyst burden. Results CBD median diameter [interquartile range, IQR, 25%, 75%] was 22% larger in ADPKD compared to controls (5.6 [4.7, 6.9] mm vs. 4.6 [3.9, 5.4] mm, p < 0.001). CBD diameter measurements had excellent inter-observer agreement (Intraclass correlation coefficient = 0.92). Thirteen (5.1%) ADPKD subjects had a CBD diameter ≥ 10 mm compared to 1 (0.4%) control subject (p < 0.001). Multivariable analysis found the presence of PKD1 or PKD2 mutation (beta = 1.5, P < 0.001) and age (beta = 0.04, p < 0.001) to be associated with increased CBD diameter and serum albumin associated with decreased CBD diameter (beta=-0.39, p < 0.001). Conclusion ADPKD subjects had 22% larger CBD diameters than in non-ADPKD controls and were more likely to have CBD dilatation ≥ 10 mm without CBD obstruction. Awareness of this association of non-obstructive CBD dilatation with ADPKD may limit unnecessary diagnostic testing.


  • Open Access

    Effects of Pregnancy on Liver and Kidney Cyst Growth Rates in Autosomal Dominant Polycystic Kidney Disease: A Pilot Study

    by Vahid Bazojoo, Vahid Davoudi, Jon D. Blumenfeld, Chenglin Zhu, Line Malha, Grace C. Lo, James M. Chevalier, Daniil Shimonov, Arman Sharbatdaran, Hreedi Dev, et al.

    Background/Objectives: Polycystic liver disease (PLD) is the most common extrarenal manifestation of autosomal dominant polycystic kidney disease (ADPKD). PLD is more prevalent in women, and women have larger liver cysts, possibly due to estrogen-related mechanisms. Maternal estrogen levels normally increase during pregnancy. Thus, we investigated the pregnancy-associated increase in liver volume, liver cyst volume, total kidney volume (TKV), and kidney cyst growth rates in ADPKD patients. Methods: Kidney, liver, and cyst volumes were measured in 16 ADPKD patients by magnetic resonance imaging (MRI) at multiple timepoints before and after pregnancy. The log-transformed TKV, liver volume, and cyst volume growth rates during a period with pregnancy were compared to a period without pregnancy. Results: In ADPKD patients, a higher annualized liver cyst growth rate was observed during a period with pregnancy compared to a period without pregnancy (34 ± 16%/yr vs. 23 ± 17%/yr; p-value = 0.005). Liver volume growth was also higher during a period with pregnancy, 6 [2, 7]%/yr vs. 0.3 [−0.4, 2]%/yr (p-value = 0.04). In addition, the mean kidney cyst growth rate was higher (12 ± 11%/yr vs. 4 ± 9%/yr; p-value = 0.05), and there was a trend toward a pregnancy-associated increase in the TKV growth rate (6 [4, 8]%/yr vs. 3 [0.8, 5]%/yr, (p-value = 0.14) during a period with pregnancy. Conclusions: In patients with ADPKD, the liver volume and cyst volume growth rates increased during pregnancy. This supports the hypothesis that the estrogen-mediated stimulation of liver cyst growth may contribute to the severe polycystic liver disease that is more prevalent in women than men with ADPKD. Further studies with larger populations are needed to explore the mechanisms and long-term implications of these findings.


  • Open Access

    Correlation Between Fixed-Luminance Flicker Full-Field Electroretinogram Response and Macular Cone Density in Healthy Individuals

    by S. Saeed Mohammadi, Woong-Sun Yoo, Negin Yavari, Hassan Khojasteh Jafari, Christopher Or, Azadeh Mobasserian, Vahid Bazojoo, Amir Akhavanrezayat, Dalia El Feky, Osama Elaraby, et al.

    This is the studyto investigate the correlation between macular cone density (MCD) and flicker electroretinogram (ERG) response in healthy eyes. In this exploratory study, 23 eyes from 12 healthy subjects were enrolled in this study. The fixed-luminance flicker full-field electroretinogram (ffERG) responses of the retina and MCDs at 24 locations were measured using the Diopsys® NOVA™ system and the rtx1 adaptive optics retinal camera, respectively. Regression analysis was employed to evaluate the correlations. The mean age of the subjects was 30 ± 3 years. The average magnitudes of the flicker response and phase response were 13.44 ± 4.88 μV and 332.63 ± 22.12°, respectively. The MCDs for all 24 locations were 15,043 ± 3511 cones/mm². Among all locations, regression analysis revealed a significant correlation only at one specific location (0, −4°) between cone density and both the mean magnitude and phase of the flicker response, with p-values of 0.005 and 0.004, respectively.In conclusion, we identified a significant correlation between MCD and ffERG responses at a specific retinal locus (0, −4°). This finding may be attributed to the distribution of different cone types throughout the retina and the possibility that various cone types may contribute differently to ERG. Further studies are required to investigate this finding.

  • Open Access

    Evaluation of the Appropriateness and Readability of ChatGPT-4 Responses to Patient Queries on Uveitis

    by S. Saeed Mohammadi, Anadi Khatri, Tanya Jain, Zheng Xian Thng, Woong-Sun Yoo, Negin Yavari, Vahid Bazojoo, Azadeh Mobasserian, Amir Akhavanrezayat, Ngoc Trong Tuong Than, et al.


  • Open Access

    Automatically Detecting Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease on MRI Using Deep Learning

    by Sophie J. Wang, Zhongxiu Hu, Collin Li, Xinzi He, Chenglin Zhu, Yin Wang, Usama Sattar, Vahid Bazojoo, Hui Yi Ng He, Jon D. Blumenfeld, et al.

    Background: Pancreatic cysts in autosomal dominant polycystic kidney disease (ADPKD) correlate with PKD2 mutations, which have a different phenotype than PKD1 mutations. However, pancreatic cysts are commonly overlooked by radiologists. Here, we automate the detection of pancreatic cysts on abdominal MRI in ADPKD. Methods: Eight nnU-Net-based segmentation models with 2D or 3D configuration and various loss functions were trained on positive-only or positive-and-negative datasets, comprising axial and coronal T2-weighted MR images from 254 scans on 146 ADPKD patients with pancreatic cysts labeled independently by two radiologists. Model performance was evaluated on test subjects unseen in training, comprising 40 internal, 40 external, and 23 test–retest reproducibility ADPKD patients. Results: Two radiologists agreed on 52% of cysts labeled on training data, and 33%/25% on internal/external test datasets. The 2D model with a loss of combined dice similarity coefficient and cross-entropy trained with the dataset with both positive and negative cases produced an optimal dice score of 0.7 ± 0.5/0.8 ± 0.4 at the voxel level on internal/external validation and was thus used as the best-performing model. In the test–retest, the optimal model showed superior reproducibility (83% agreement between scan A and B) in segmenting pancreatic cysts compared to six expert observers (77% agreement). In the internal/external validation, the optimal model showed high specificity of 94%/100% but limited sensitivity of 20%/24%. Conclusions: Labeling pancreatic cysts on T2 images of the abdomen in patients with ADPKD is challenging, deep learning can help the automated detection of pancreatic cysts, and further image quality improvement is warranted.


  • Open Access

    A Primer for Utilizing Deep Learning and Abdominal MRI Imaging Features to Monitor Autosomal Dominant Polycystic Kidney Disease Progression

    by Chenglin Zhu, Xinzi He, Jon D. Blumenfeld, Zhongxiu Hu, Hreedi Dev, Usama Sattar, Vahid Bazojoo, Arman Sharbatdaran, Mohit Aspal, Dominick Romano, et al.

    Abdominal imaging of autosomal dominant polycystic kidney disease (ADPKD) has historically focused on detecting complications such as cyst rupture, cyst infection, obstructing renal calculi, and pyelonephritis; discriminating complex cysts from renal cell carcinoma; and identifying sources of abdominal pain. Many imaging features of ADPKD are incompletely evaluated or not deemed to be clinically significant, and because of this, treatment options are limited. However, total kidney volume (TKV) measurement has become important for assessing the risk of disease progression (i.e., Mayo Imaging Classification) and predicting tolvaptan treatment’s efficacy. Deep learning for segmenting the kidneys has improved these measurements’ speed, accuracy, and reproducibility. Deep learning models can also segment other organs and tissues, extracting additional biomarkers to characterize the extent to which extrarenal manifestations complicate ADPKD. In this concept paper, we demonstrate how deep learning may be applied to measure the TKV and how it can be extended to measure additional features of this disease.


  • The Role of Corticosteroids and Immunomodulatory Therapy in the Management of Infectious Uveitis

    by Amir Akhavanrezayat, Gunay Uludag Kirimli, Wataru Matsumiya, Hassan Khojasteh, Christopher Or, Irmak Karaca, Brandon Pham, Prapatsorn Ongpalakorn, Sherin Lajevardi, Brandon Lam, et al.

    The index review aims to provide an update on the role of corticosteroids and steroid-sparing immunomodulatory therapy (IMT) in managing patients with infectious uveitis. Narrative literature review. Corticosteroids and immunomodulatory therapy (IMT) focus on the host defense system instead of the pathogen, adjusting exaggerated inflammatory reactions to reduce potential harm to ocular tissues. Systemic or local corticosteroids are primarily selected as adjunctive medication for infectious uveitis. Concomitant corticosteroids have also been used in cases of paradoxical worsening in ocular tuberculosis and immune recovery uveitis in cytomegalovirus (CMV) retinitis. While there is no well-established evidence to support the use of IMT in infectious uveitis, it is occasionally used in clinical settings to treat persistent inflammation following resolution of infection such as cases of ocular tuberculosis and ocular syphilis where an insufficient response is observed with corticosteroids. There is no consensus on the position of immunomodulatory therapy in the management of infectious uveitis with different etiologies. The index review provides an overview of available adjunctive corticosteroids and IMT options to assist clinicians in managing such disease entities more efficiently.


  • Open Access

    Neurosarcoidosis, Coccidioidomycosis, or Both!

    by Amir Akhavanrezayat, Wataru Matsumiya, Prapatsorn Ongpalakorn, Hashem H Ghoraba, Chris Or, Hassan Khojasteh Jafari, Gunay Uludag Kirimli, Cigdem Yasar, Ngoc Trong Tuong Than, Irmak Karaca, et al.

    Purpose: To report a case of neurosarcoidosis (NS) who was initially diagnosed as Coccidioidomycosis immitis (CI) infection. Observations: A 57-year-old diabetic man presented with sudden painless diminution of vision, metamorphopsia, and color vision deficits in the left eye (OS) for one month. His vision was 20/20 in the right eye (OD) and 20/40 OS. Ophthalmic examination revealed left relative afferent pupillary defect, blurred optic nerve margin, creamy chorioretinal infiltration around the optic disc, and mild macular edema. OD examination was non-revealing. Chest CT scan with contrast showed calcified mediastinal lymph nodes, but biopsy of the lymph nodes was normal. Brain and orbit MRI demonstrated soft tissue abnormality with enhancement in left orbital apex with involvement of the extraocular muscles. CSF culture was negative, but complement fixation had positive titer of 1:2 for CI. The patient was diagnosed with CI meningitis, and antifungal therapy was initiated. Slight visual and symptomatic improvement was observed, which was not completely satisfactory. Biopsy of extraocular orbital muscle five months later revealed non-caseating granulomatous inflammation, leading to initiation of prednisone trial therapy. Nine months later, the patient was referred to a tertiary center owing to persistence of optic disc edema OS. PET CT was consistent with a diagnosis of sarcoidosis. Antifungal treatment was discontinued, and oral prednisone with methotrexate was initiated. Subsequently, methotrexate was replaced by infliximab to further manage ocular inflammation and neurologic symptoms which was effective. Vision was 20/20 OD and 20/30 OS at the most recent visit. Conclusion and Importance: Signs and symptoms of neurosarcoidosis and coccidioidomycosis can be similar and deceiving. The index case underscores importance of considering appropriate differential diagnoses in patients with similar symptoms and signs who may respond to preliminary designated treatment but not to the optimal extent. Considering such possibility could assist clinicians in managing the patients timely and efficiently.